CureDuchenne and Prosensa Holding N.V. (NASDAQ: RNA) have been selected to present at the 6th annual Partnering for Cures, November 16-18 in New York City. Convened by FasterCures, the Washington, D.C.-based center of the Milken Institute, the conference will bring together nearly 1,000 medical research leaders, investors and decision-makers to forge the collaborations needed to speed and improve outcomes-driven R&D. CureDuchenne, a nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy, and Prosensa, the biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, will present “Accelerating Access to Treatments of Duchenne Muscular Dystrophy” on November 17. The presentation will focus on CureDuchenne and Prosensa’s $7 million (€5M) collaboration.
Help employers find you! Check out all the jobs and post your resume.
